Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.085
+0.025 (2.36%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Organigram Global Revenue
Organigram Global had revenue of 42.73M CAD in the quarter ending December 31, 2024, with 17.21% growth. This brings the company's revenue in the last twelve months to 166.12M, down -0.18% year-over-year. In the fiscal year ending September 30, 2024, Organigram Global had annual revenue of 159.84M with 7.13% growth.
Revenue (ttm)
166.12M CAD
Revenue Growth
-0.18%
P/S Ratio
1.26
Revenue / Employee
184,984 CAD
Employees
898
Market Cap
145.64M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 159.84M | 10.64M | 7.13% |
Sep 30, 2023 | 149.21M | 3.40M | 2.33% |
Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
Aug 31, 2019 | Pro | Pro | Pro |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Aug 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OGI News
- 1 day ago - Organigram Global Shares Recording of its OG Investor Session - Business Wire
- 7 days ago - New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future - Business Wire
- 21 days ago - Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ - Business Wire
- 22 days ago - Organigram Enters U.S. Through Acquisition of Collective Project Beverages - Business Wire
- 4 weeks ago - Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence - Business Wire
- 4 weeks ago - Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc. - Business Wire
- 7 weeks ago - Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment - Business Wire
- 2 months ago - Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks - Seeking Alpha